Department of Emergency, The Affiliated Baoan Hospital of Southern Medical University, The People's Hospital of Baoan Shenzhen, Shenzhen, China.
Department of Nursing, The Affiliated Hospital of Shenzhen University, The Second People's Hospital of Shenzhen, Shenzhen, China.
BMC Geriatr. 2019 Jul 3;19(1):183. doi: 10.1186/s12877-019-1195-y.
Previous cohort studies investigating the association between sarcopenic obesity (SO) and all-cause mortality among adult people have been inconsistent. We performed a meta-analysis to determine if SO is a predictor of all-cause mortality.
Prospective cohort studies that evaluated the association between SO and mortality in older people were identified via a systematic search of three electronic databases (PubMed, EMBASE, and the Cochrane Library). A random-effects model was applied to combine the results. We considered the methods recommeded by consensuses (dual X-ray absorptiometry,bio-impedancemetry, anthropometric measures or CT scan) to assess sarcopenic obesity.
Of the 603 studies identified through the systematic review, 23 (Participants: 50866) were included in the meta-analysis. The mean age ranged from 50 to 82.5 years.SO was significantly associated with a higher risk of all-cause mortality among adult people (pooled HR = 1.21, 95% confidence interval [95% CI] = 1.10-1.32, p < 0.001, I = 64.3%). Furthermore, the subgroup analysis of participants showed that SO was associated with all-cause mortality (pooled HR = 1.14, 95% CI: 1.06-1.23) among community-dwelling adult people; similarly, this association was found in hospitalized patients (pooled HR = 1.65, 95% CI: 1.17-2.33). Moreover, the subgroup analysis demonstrated that SO was associated with all-cause mortality when using skeletal muscle mass (SMM) criteria, muscle strength criteria, and skeletal muscle index (SMI) criteria (HR = 1.12, 95% CI: 1.01-1.23; HR = 1.18, 95% CI: 1.05-1.33; and HR = 1.53, 95% CI: 1.13-2.07, respectively). In addition, we analyzed SO on the basis of obesity definition and demonstrated that participants with a SO diagnosis based on waist circumference (WC) (HR = 1.24, 95% CI: 1.09-1.40), body mass index (BMI) (HR = 1.29, 95% CI: 1.04-1.59), or visceral fat area (HR = 2.54, 95% CI: 1.83-3.53) have a significantly increase mortality risk compared with those without SO.
Based on our update of existing scientific researches, SO is a significant predictor of all-cause mortality among older people, particularly hospitalized patients. Therefore, it is important to diagnose SO and to treat the condition to reduce mortality rates among older people.
之前的队列研究调查了成人中肌少症性肥胖(SO)与全因死亡率之间的关联,但结果并不一致。我们进行了一项荟萃分析,以确定 SO 是否是全因死亡率的预测因素。
通过系统检索三个电子数据库(PubMed、EMBASE 和 Cochrane Library),确定了评估老年人 SO 与死亡率之间关联的前瞻性队列研究。应用随机效应模型合并结果。我们考虑了共识推荐的方法(双能 X 线吸收法、生物电阻抗法、人体测量学指标或 CT 扫描)来评估肌少症性肥胖。
通过系统综述共确定了 603 项研究,其中 23 项(参与者:50866 人)纳入荟萃分析。平均年龄为 50 至 82.5 岁。SO 与成年人全因死亡率升高显著相关(合并 HR=1.21,95%置信区间 [95%CI]=1.10-1.32,p<0.001,I=64.3%)。此外,参与者的亚组分析表明,SO 与社区居住的成年人的全因死亡率相关(合并 HR=1.14,95%CI:1.06-1.23);同样,在住院患者中也发现了这种关联(合并 HR=1.65,95%CI:1.17-2.33)。此外,亚组分析表明,当使用骨骼肌质量(SMM)标准、肌肉力量标准和骨骼肌指数(SMI)标准时,SO 与全因死亡率相关(HR=1.12,95%CI:1.01-1.23;HR=1.18,95%CI:1.05-1.33;HR=1.53,95%CI:1.13-2.07)。此外,我们根据肥胖定义分析了 SO,并表明基于腰围(WC)(HR=1.24,95%CI:1.09-1.40)、体重指数(BMI)(HR=1.29,95%CI:1.04-1.59)或内脏脂肪面积(HR=2.54,95%CI:1.83-3.53)诊断为 SO 的参与者与无 SO 的参与者相比,死亡风险显著增加。
基于我们对现有科学研究的更新,SO 是老年人全因死亡率的一个显著预测因素,特别是住院患者。因此,诊断 SO 并治疗该疾病对于降低老年人的死亡率非常重要。